Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Con-ciencia (La Paz) ; 5(2): 81-95, nov. 2017. ilus., tab.
Article in Spanish | LILACS | ID: biblio-1178836

ABSTRACT

El presente es un estudio de tipo descriptivo no experimental para determinar sangre oculta de heces (SOH) en población aparentemente sana. La presencia de SOH, puede estar relacionada con varias causas, como gastritis, úlcera péptica o duodenal, parasitosis intestinal, sangrado de encías o cáncer colorectal. Se analizaron 1093 muestras de heces fecales provenientes de estudiantes que cursaban la cátedra de Anatomía y Fisiología de la FCFB de la UMSA y su entorno familiar. Utilizando el método inmunocromatográfico (SUMASOHF), todos los investigadores que participaron fueron capacitados para realizar el análisis. Las muestras se procesaron, por duplicado y aquellas que dieron resultado positivo, se procesaron nuevamente. Los resultados se analizaron con el programa estadístico SPSS 22. Se encontró presencia de SOH en el 16,1% de todas las muestras procesadas. El porcentaje de casos positivos de SOH fue ligeramente superior en el género masculino y en el grupo etario de 61-80 años. En el grupo de fumadores se reveló un 24.50% de casos positivos y un 19.20% en las personas que declararon consumir bebidas alcohólicas. También se consideraron otras causas de SOH, como la insuficiencia cardiaca, la gastritis, la ingestión de medicamentos como la aspirina y el ibuprofeno. A todos los casos que dieron positivo de SOH, se recomendó consultar con su médico para realizar otros exámenes más específicos. En conclusión la pérdida de sangre por heces fecales es un problema, que puede pasar desapercibido por la ausencia de sintomatología; por lo tanto, sugerimos que esta prueba sea incluida en la evaluación rutinaria de pacientes.


A descriptive, non-experimental study was carried out to determine the presence of fecal occult blood (SOH) considering its relation with the early diagnosis of colorectal cancer. We analyzed 1093 fecal samples from students who were in the Chair of Anatomy and Physiology of the FCFB of UMSA and their family environment. Using the immunochromatographic method (SUMASOHF), all the researchers who participated were trained to perform the analysis. The samples were processed in the laboratory of Anatomy and Physiology, using a inmunocromatographic metod, (SUMASOHF). The investigatours were trained to perform the test and the samples were processed with the supervision of the professors. All samples were processed in duplicate and all positive samples were reprocessed. All results were registrated in the correspondy datasheet. The data were analysed using the a statistical program SPSS 22. We found presence of fecal occult blood in 16.1 % of the samples. The percentage of positive cases of SOH in the male gender was slightly higher compared to the number of positive cases was higher in goner of 61 to 80 age group. In the group of smokers revealed a 24.50% of positive cases and 19.20% in the group that consumes alcohol. Other causes of SOH were also investigated such as heart failure, gastritis, ingestion of drugs such as aspirin and ibuprofen. In some cases, no probable cause of bleeding was found. It was recommended to all participant with a positive test, consult their doctors for more specific diagnosis. Here were concluded that stool blood loss is a problem, which is ignored since there is absence of symptomatology, therefore, we suggest that this test be included in the routine evaluation of patients.


Subject(s)
Parasitic Diseases , Occult Blood , Patients , Peptic Ulcer , Ibuprofen , Feces , Smokers , Gastritis
2.
Acta neurol. colomb ; 31(4): 391-397, oct. 2015. ilus, tab
Article in Spanish | LILACS | ID: lil-776250

ABSTRACT

Introducción: Existe escasa información en Colombia acerca de la discapacidad en enfermedad cerebrovascular isquémica (ECVi) y fibrilación auricular (FA). Objetivo: Determinar la prevalencia y los factores asociados a discapacidad moderada a severa en pacientes con ECVi y FA. Materiales y métodos: Se analizó una serie consecutiva de pacientes con ECVi y FA, que ingresó de julio de 2013 a febrero de 2014, con estancia hospitalaria de 11,88 ± 8,1 días. Analizamos la prevalencia puntual, discapacidad (eRm) y mortalidad al egreso. Resultados: Pacientes con ECVi: 368; de ellos, 63 (17%) con FA (54% hombres; 77,6 ± 10,25 años), hipertensión arterial (77,8%), ECVi previo (58,7%), cardiopatía dilatada (46%), antiplaquetarios o anticoagulantes previos (58,7%), arteria cerebral media (74,6%), infartos parciales circulación anterior (PACI) (47,6%), dilatación auricular (60,3%), afasia (36,5%), convulsión (7,9%), discapacidad moderada a severa (eRm 3-5) (41,3%) y mortalidad (17,4%). Observamos que el sexo femenino (OR 3,68; IC 1,01-13,39; p = 0,048), ECVi previo (OR 3,94; IC 1,15-13,57; p = 0,03) y afasia (OR 6,86; IC 1,7-27,66; p = 0,007) fueron factores asociados independientes para discapacidad moderada-severa y mortalidad. Conclusión: En esta serie el sexo femenino, antecedente de ECVi previo y afasia, son los principales factores asociados a morbimortalidad en nuestros pacientes.


Introduction: There is little information in Colombia about ischemic stroke and Atrial Fibrillation (AF) disability. Objective: The aim of this study was to determine the prevalence and factors associated with moderate to severe disability in patients with stroke and AF. Materials and methods: We analyzed consecutive cases with stroke and AF, admitted from July 2013 to February 2014 hospital stay 11.88 ± 8.1 days was analyzed. We analyze the prevalence, disability (mRs) and mortality at discharge. Results: 368 patients with ischemic stroke and 63 (17%) with AF (54% male), aged (77.6 ± 10.25 years), hypertension (77.8%), prior stroke (58.7%), Heart Failure (46%), prior antiplatelet or anticoagulant treatment (58.7%), Middle Cerebral Artery (74.6%), partial anterior circulation infarcts (PACI) (47.6%), atrial dilatation (60.3%), aphasia (36.5%), seizures (7.9%), moderate and severe disability (eRm 3-5) (41.3%) and deaths (17.4%). We observed that female gender (OR 3.68; CI 1.01-13.39; p = 0.048. ), Prior CVD (OR 3.94; CI 1.15-13.57; p = 0.03) and aphasia (OR 6.86; CI 1.7-27.66; p = 0.007) were independent factors associated with moderate to severe disability and mortality. Conclusion: In this series the female sex, history of prior CVD and aphasia are the main factors associated with morbidity and death in our patients.

4.
Southeast Asian J Trop Med Public Health ; 1993 Dec; 24(4): 617-23
Article in English | IMSEAR | ID: sea-35495

ABSTRACT

In three provinces of the Philippines (Quezon, Northern Samar and Zamboanga del Sur), 11,378 children between 6 and 83 months of age were examined for signs of xerophthalmia and weighed to determine weight-for-age status. Xerophthalmia prevalence ranged from 1.6% to 4.4% for nightblindness and 0.6% to 2.7% for Bilot's spots in the three provinces indicating a serious vitamin A deficiency problem. These levels contrast sharply with the recent national xerophthalmia prevalence (0.7% for night blindness and 0.2% for Bitot's spots). There was a preponderance of mild xerophthalmia among males, and among children 4-6 years of age. No consistent association between weight-for-age status and xerophthalmia was found. The study recommends the universal distribution of vitamin A to children in high-prevalence regions, rather than the current practice of providing vitamin A supplements to moderately and severely underweight children identified through the annual village-based child weighing sessions, to ensure reaching children most at risk for xerophthalmia. The study also suggests the need for regional vitamin A assessments to identify areas endemic for vitamin A deficiency because the aggregate national prevalence may mask a more serious localized problem.


Subject(s)
Child , Child Nutritional Physiological Phenomena , Child, Preschool , Demography , Female , Humans , Infant , Male , Nutrition Disorders/epidemiology , Nutritional Status , Philippines/epidemiology , Prevalence , Vitamin A Deficiency/complications , Xerophthalmia/complications
SELECTION OF CITATIONS
SEARCH DETAIL